The Journal of nervous and mental disease · 2026
Metacognitive Interpersonal Group Therapy for Adolescents With Personality Disorders: Results From the METAMIND-A Pilot Randomized Controlled Trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Inchausti Felix, García-Poveda Nancy V, Ballesteros-Prados Alejandro, Fonseca-Pedrero Eduardo, MacBeth Angus, Popolo Raffaele, Dimaggio Giancarlo
Аннотация
AIM: This pilot RCT evaluated the feasibility, acceptability, and preliminary effects of Metacognitive Interpersonal Group Therapy for Adolescents (MIT-GA) compared with waiting list plus treatment-as-usual (WL+TAU).
METHODS: One hundred adolescents (14-18 years) meeting DSM-IV criteria for PDs (excluding antisocial PD) were randomized to MIT-GA or WL+TAU for 4 months. Primary outcomes included treatment acceptability, psychosocial functioning (CGAS, IIP-64), and symptom severity (SCL-90-R GSI). Secondary outcomes were depression (Y-BDI), caregiver stress (PSS), and parental self-efficacy (BPSES). Mechanisms of change included metacognition (MAS-A), alexithymia (TAS-20), and impulsivity (BIS-11).
RESULTS: MIT-GA participants showed greater improvements in psychosocial functioning ( d = 0.80) and parental stress ( d = 0.65) versus WL+TAU. No significant between-group differences were found in overall symptom severity. MIT-GA also improved metacognition, alexithymia, and attentional impulsivity. No adverse events were reported.
CONCLUSIONS: These findings support the feasibility and potential utility of MIT-GA for adolescents with PDs.
METHODS: One hundred adolescents (14-18 years) meeting DSM-IV criteria for PDs (excluding antisocial PD) were randomized to MIT-GA or WL+TAU for 4 months. Primary outcomes included treatment acceptability, psychosocial functioning (CGAS, IIP-64), and symptom severity (SCL-90-R GSI). Secondary outcomes were depression (Y-BDI), caregiver stress (PSS), and parental self-efficacy (BPSES). Mechanisms of change included metacognition (MAS-A), alexithymia (TAS-20), and impulsivity (BIS-11).
RESULTS: MIT-GA participants showed greater improvements in psychosocial functioning ( d = 0.80) and parental stress ( d = 0.65) versus WL+TAU. No significant between-group differences were found in overall symptom severity. MIT-GA also improved metacognition, alexithymia, and attentional impulsivity. No adverse events were reported.
CONCLUSIONS: These findings support the feasibility and potential utility of MIT-GA for adolescents with PDs.